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ABSTRACT 
The purpose of this thesis is to analyze gene expression in grapevine under different 
treatments using a mixed linear statistical model. The experiment involves two Vitis 
species (V. vinifera Cabernet sauvignon and V. aestivalis Norton) and applies two 
different treatments to them (inoculation with Erysiphe necator conidiospores and mock 
inoculation).  There are three biological replicates measured at each of the following six 
assigned time points: 0, 4, 8, 12, 24, and 48 hours. By setting up split-plot model for the 
data, statistical hypotheses concerning gene expressions, especially gene expressions in 
terms of treatment effect, are tested. The result of the analysis identify those genes 
expressed differently, and further experiments will indicate biological properties of those 
specific genes. After performing the analysis by using the split-plot model, discussions 
about another possible model, repeated measures design, is introduced at the end of this 
thesis in order to incorporate the potential biological property, such as diurnal pattern, 
into the modeling and analysis. By these series of analysis, certain genes are found with 
different expression, such as the gene with ID 000002 and ID 000004. This result will be 
useful in further biological researches.  
 
 
 
 
KEYWORDS:  gene expression profiling, residual analysis, data transformation and 
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CHAPTER 1: INTRODUCTION 
 
Understanding how the genome of an organism function is primary focus of 
modern biology research. The high cost of generating functional genomics data requires 
researchers to use experimental material as efficiently as possible, and expectations are 
that the data are analyzed with great precision. Usually, genomic studies involve a large 
number of observations, and the downstream analysis and interpretation of the resulting 
vast datasets is challenging. In order to gather information from data, substantial biology 
knowledge and statistical technique have to be applied in combination.  
Functional genomics is a powerful tool to improve the health and productivity of 
agricultural plants. Researchers conducted an experiment involving two Vitis species, two 
treatments, and made three measurements at each of six assigned time points. This 
experiment involves the following:  
1. Two Vitis species: V. vinifera Cabernet sauvignon (CS) and V. aestivalis 
Norton (N); 
 
2. Two treatments applied to each species: inoculation with E. necator 
conidiospores (INC) and mock inoculation (MOC); 
 
3. Observations at six time points for each species under each treatment: 0 hour, 
4 hours, 8 hours, 12 hours, 24 hours, 48 hours; 
 
4. Three biological replicates are made at each time point for each species under 
each treatment. 
 
The main purpose of this experiment is to monitor the expression levels of 16436 
Vitis genes across the two treatments. Statistical methods are applied to analyze the signal 
levels of each of these 16436 genes to assess the significance of the differences between 
these two treatments.  The ultimate goal is to differentiate those genes that express at 
 2 
significantly different level the treatments. In this procedure, we have to set up an 
appropriate statistical model from the data observed in experiment. Statistical hypothesis 
testing will be used, as well. For this certain experiment, we will use split-plot 
experiment design to model the data researchers got from experiment. In Chapter 2, we 
will use observations of one gene to explain how split-plot experiment design works and 
define related concepts, such as whole-plot and split-plot, and then we will interpret what 
the general split-plot model looks like. The split-plot model will be applied to all genes’ 
observations to analyze gene expressions in Chapter 3. Chapter 4 will discuss whether 
there are other experiment design models which would be more appropriate to be applied, 
such as repeated measurement (experiment design) model, which will be discussed later 
in this thesis. And finally, Chapter 5 will contain a summary of all results and 
conclusions got from previous chapters. 
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CHAPTER 2: SPLIT-PLOT DESIGN 
 
Split-plot designs are extremely popular in experimental design since they cover a 
common case in real world, which is when you have a factor that you want to study but 
cannot change as often as your other factors. In a factorial experimental arrangement, 
however, it is not always possible or practical to completely randomize the order of 
experiment and to obtain genuine independent replicates. These practical conditions or 
restrictions lead to a split-plot design. The following data are the signal values of a gene 
(called GENE00001) in the grapevine study which will be used to explain split-plot 
model. 
 
Section 2.1 Example 
Let us use the single stage Split-plot design as an example; models for multiple 
stages cases are derived similarly. 
Consider observations of first gene (with ID GENE00001). We select the first 
replicates only at each time point as an example here to explain how the split-plot model 
work. Recall that we have two species, Cabernet sauvignon (CS) and Norton (N); two 
treatments, Inoculation with Erysiphe - necator conidiospores (INO) and mock 
inoculation (MOC); and that there are six assigned time points (0, 4, 8, 12, 24, 48 hours) 
for each species and each treatment.  
Table 2.1.1 shows the sample data. It is clear that the four combinations of species 
and treatments, CS and INO, CS and MOC, N and INO, N and MOC, make four small 
groups or blocks. This gives a general randomized block structure. Six time points divide 
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each small group into six subgroups. These three factors, SPECIES, TREATMENT, and 
TIME are fixed factors. By viewing Table 2.1.1, you might think of this experiment as a 
2×2×6 factorial design with one replication per cell. However, in a completely 
randomized factorial experiment, researchers would have to grow, for instance, 60 
Cabernet sauvignon (CS) plants and apply Inoculation with E. necator conidiospores 
(INO). After the inoculation, they need to randomly select a time point from the hours 0, 
4, 8, 12, 24, and 48, say 8, and then at the 8-hour time point, they need to harvest 10 
leaves, one from each plant, to make one GeneChip in order to obtain observations. 
Similar procedures have to be done six times, to get all the six observations. Of course, 
this is not possible or practically not feasible! We would argue that other ways of 
carrying out the randomization is too expensive.  
 
Table 2.1.1: Observations of GENE00001 (with First Replicate Signals Only) 
Species Treatment Time Observation Species Treatment Time Observation 
CS INO 0 2416.7 N INO 0 2711.2 
CS INO 4 2519.7 N INO 4 2745.4 
CS INO 8 2704 N INO 8 2769.7 
CS INO 12 2434.6 N INO 12 2347.3 
CS INO 24 2834 N INO 24 2439.2 
CS INO 48 2680 N INO 48 2662.2 
CS MOC 0 2819.2 N MOC 0 2507.6 
CS MOC 4 3151.8 N MOC 4 2587.9 
CS MOC 8 2262.5 N MOC 8 2255.9 
CS MOC 12 2254.5 N MOC 12 2453.9 
CS MOC 24 3105.1 N MOC 24 2476.5 
CS MOC 48 3019.2 N MOC 48 2678.3 
 
What really happened is the experiment was done in a split-plot design setting. 
After the inoculation, experimenters randomly select 10 plants to produce the first 
GeneChip at time 0 (hour), at time 4 (4 hours later) randomly select another set of 10 
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plants to produce the second GeneChip, and so on.  The entire experiment was replicated 
for other three treatment combinations (CS and MOC, N and INO, and N and MOC). 
These four treatment combinations are the whole plots, and time points (0, 4, 8, 12, 24, 
and 48) are the split-plots. The effects of the whole plot are confounded with the replicate 
effects. 
 Apart from those we discussed above, we might think that time effects are nested 
within each species and treatment combination, but actually they are not since each time 
point crossed with all species and treatment combinations.  
Taking all effects into consideration, the split-plot model for this experiment is: 
Model 1: Yijk = µ + αi + θj + (αθ)ij + βk+ (αβ)ik + (θβ)jk  + (αθβ)ijk  + εijk 
Where 
µ is the grand mean; 
αi is the species effect for the ith species; 
θj is the treatment for the jth treatment; 
(αθ)ij  is the interaction effect between the ith species and the  jth treatment; 
βk  is the time effect for the kth time point; 
(αβ)ik  is the interaction effect for the ith species at the kth time point; 
(θβ)jk  is the interaction effect for the jth treatment at the kth time point; 
(αθβ)ijk is the interaction effect for the ith species with the  jth treatment applied at the kth 
time point; 
εijk is the random error term. 
With those assumptions listed above, we can start to derive Sum of Squares and 
prepare for ANOVA table to do further analysis. For i = 1, 2; j = 1, 2; k = 1, 2.  yijk is 
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observations.  y… is defined as overall mean. yi..,y.j.,  y..k represent mean of all 
observations of ith species, mean of all observations of jth treatment, and mean of all 
observations of kth time points, respectively. yij.,yi.k, y.jk are mean of all observations of 
ith species applied with jth treatment, mean of all observations of ith species at kth time 
points and mean of all observations of jth treatment at kth time points, respectively.  
Assumptions are involved.  θj   ̴  N(0, σθ2), (αθ)ij   ̴  N(0, σαθ2), (θβ)jk   ̴  N(0, 
σθβ2), (αθβ)ijk   ̴  N(0, σαθβ2), εijk   ̴ N(0, σε2) and they are mutually independent for i = 
1, 2; j = 1, 2; k = 1, 2,…, 6. 
∑∑∑(yijk − y…)
2
6
k=1
2
j=1
2
i=1
 
= 2 × 6∑(yi.. − y…)
2
m
i=1
+ 2 × 6∑(y.j. − y…)
2
2
j=1
+ 6∑∑(yij. − yi.. − y.j. + y…)
2
2
j=1
2
i=1
 
+2 × 2∑(y..k − y…)
2
6
k=1
+ 2∑∑(yi.k − yi.. − y..k + y…)
2
6
k=1
2
i=1
 
+2∑∑(y.jk − y.j. − y..k + y…)
2
6
k=1
2
j=1
 
+∑∑∑(yijk − yij. − yi.k − y.jk + yi.. + y.j. + y..k + y…)
2
6
k=1
2
j=1
2
i=1
 
That is, SSTotal = SSSpecies + SSTreatment + SSSpecies×Treatment + SSTime+ SSSpecies×Time + 
SSTreatment×Time + SSSpecies×Treatment×Time. Specifically, we can get these results:  
SSTotal = ∑ ∑ ∑ (𝑦𝑖𝑗𝑘 − 𝑦…)
26
𝑘=1
2
𝑗=1
2
𝑖=1 ; d.f. = 2×2×6 - 1 
SSSpecies = 2 × 6∑ (𝑦𝑖.. − 𝑦…)
22
𝑖=1 ; d.f. = 2-1 
SSTreatment = 2 × 6∑ (𝑦.𝑗. − 𝑦…)
22
𝑗=1 ; d.f. = 2-1 
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SSSpecies×Treatment = 6∑ ∑ (𝑦𝑖𝑗. − 𝑦𝑖.. − 𝑦.𝑗. + 𝑦…)
22
𝑗=1
2
𝑖=1 ; d.f. = (2-1) (2-1) 
SSTime = 2 × 2∑ (𝑦..𝑘 − 𝑦…)
26
𝑘=1 ; d.f. = 6-1 
SSSpecies×Time = 2∑ ∑ (𝑦𝑖.𝑘 − 𝑦𝑖.. − 𝑦..𝑘 + 𝑦…)
26
𝑘=1
2
𝑖=1 ; d.f. = (2-1) (6-1) 
SSTreatment×Time = 2∑ ∑ (𝑦.𝑗𝑘 − 𝑦.𝑗. − 𝑦..𝑘 + 𝑦…)
26
𝑘=1
2
𝑗=1 ; d.f. = (2-1) (6-1) 
SSSpecies×Treatment×Time = ∑ ∑ ∑ (𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗. − 𝑦𝑖.𝑘 − 𝑦.𝑗𝑘 + 𝑦𝑖.. + 𝑦.𝑗. + 𝑦..𝑘 + 𝑦…)
26
𝑘=1
2
𝑗=1
2
𝑖=1 ; 
d.f. = (2-1) (2-1) (6-1) 
On the procedure of deriving, we cannot find any expression to estimate the sum 
of square of our error term εijk; in other words, the error term in the model above is not 
estimable. Split-plot design has both whole plots and split-plots, which leads to multiple 
error term for different plot levels. In terms of this, when doing analysis and hypothesis 
testing, we should figure out which term to use as error term.  
Since we define SPECIES and TREATMENT as whole-plot factors, we can 
consider the interaction effect of SPECIES and TREATMENT as the error term within 
whole-plot level. We consider the interaction between treatment and species to be a 
random effect since the interaction effect is different for each species and each treatment. 
We can only control the treatment and the species, but we cannot control or predict the 
effect of this interaction.  Applying similar logic to split-plot level, interaction effect of 
SPECIES, TREATMENT and TIME will be a possible error term to use in doing 
analysis. In fact, there exists statistical reason to doing this prediction. How to determine 
these error is shown in Table 2.1.2. Details of each term in the EMS column will be 
discussed in Appendix II. Table 2.1.2 classifies all factors into whole-plot factors and 
split-plot factors and gives degree of freedom directly, which is convenient. We have 
another thing to do before analysis, which is, normalizing data. Due to all normal 
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assumptions we made above for our model, we have to check if our data is (approximate) 
normally distributed, or not. For raw data listed in Table 2.1.1, we can get histogram as 
what shows in Figure 2.1. 
 
Table2.1.2: EMS (Error of Mean Squares) of model for GENE00001 sample (with first 
replicates only) 
 
 Sources d.f. 
2 2 6 
EMS  
F R F 
i j k 
Whole 
plot 
αi 2-1 0 2 6 σε2 + 6σαθ2 + 2×6 
∑ 𝛼𝑖
2
𝑖
2−1
 
θj 
2-1 2 1 6 σε2 + 2×6
∑ 𝜃𝑗
2
𝑗
2−1
 
(αθ)ij (2-1)(2-1) 0 1 6 σε2 + 6σαθ2  
Split 
plot 
βk 6-1 0 2 0 
σε2 + 2 𝜎𝛼𝜃𝛽
2 + 2
∑ ∑ (𝜃𝛽)𝑗𝑘
2
𝑘𝑗
(2−1)(6−1)
 
+ 2×2 
∑ 𝛽𝑘
2
𝑘
6−1
       
(αβ)ik (2-1)(6-1) 0 2 0 σε2 + 2 𝜎𝛼𝜃𝛽
2+ 2 
∑ ∑ (𝛼𝛽)𝑖𝑗
2
𝑗𝑖
(2−1)(6−1)
 
(θβ)jk (2-1)(6-1) 0 1 0 σε
2 + 2 𝜎𝛼𝜃𝛽
2                                        
(αθβ)ijk (2-1)(2-1)(6-1) 0 1 0 σε
2 + 𝜎𝛼𝜃𝛽
2 
εijk  1 1 1 σε2 (not estimable) 
 Total 2×2×6-1     
 
The raw data of this sample is approximately bell-shaped (referring to Figure 2.1), 
except that the data range from 2000 to 3400. The magnitude of raw data is too large, 
which increases noise effects. Normalization is necessary here. Usually, two method will 
be used. One is making log-transformation. Log-transformation decrease the magnitude 
of the data. The other is finding z-scores for each of the observations. Z-scores 
calculation forces data to be normally distributed. This approach usually is used when the 
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histogram of data is not close to bell-shaped at all. For our sample data, the original 
histogram is already close to the histogram of normal distribution, so log-transformation 
should be enough. The basic idea is transform our raw data into log2 (raw data + 1). The 
reason for adding 1 is to avoid the case when some observations are zeros. After doing 
this, we will get the data and its histogram as shown in Table 2.1.3.  
 
 
Figure 2.1 Histogram for raw data of GENE00001 (first replicate only) 
 
Notice that this histogram in Figure 2.2 has two peaks, which is different from the 
unimodal normal distribution. For most experiment, this is acceptable. We can use 
Normal QQ-plot to support our statement. In Figure 2.3, we notice all points are 
extremely close to the straight line. Once the line made by points is approximately a 
straight line, we claim that the data is approximately normal, which is totally enough for 
experimental modeling. 
2100 2300 2500 2700 2900 3100 3300
Observation
0.0000
0.0005
0.0010
0.0015
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Figure 2.2 Histogram for transformed data of GENE00001 (first replicate only) 
 
Table 2.1.3: Transformed Observations of GENE00001 sample (with first replicate 
signals only) 
Species Treatment Time Observation Specie Treatment Time Observation 
CS INO 0 11.2394 N INO 0 11.4052 
CS INO 4 11.2996 N INO 4 11.4233 
CS INO 8 11.4014 N INO 8 11.4360 
CS INO 12 11.2500 N INO 12 11.1974 
CS INO 24 11.4691 N INO 24 11.2527 
CS INO 48 11.3885 N INO 48 11.3789 
CS MOC 0 11.4615 N MOC 0 11.2926 
CS MOC 4 11.6224 N MOC 4 11.3381 
CS MOC 8 11.1443 N MOC 8 11.1401 
CS MOC 12 11.1392 N MOC 12 11.2614 
CS MOC 24 11.6008 N MOC 24 11.2746 
CS MOC 48 11.5604 N MOC 48 11.3876 
 
Now the data are ready for analysis. By using statistical software, we can get the 
following ANOVA table (referring Table 2.1.4). We can read all results of sum of 
squares we listed earlier in this chapter from the Sum of Square column, directly. Notice 
that this ANOVA table is not classified by whole-plot factor and split-plot factor, so we 
11.1 11.2 11.3 11.4 11.5 11.6 11.7
trans-obs.
0.0
0.5
1.0
1.5
2.0
2.5
3.0
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need to be really careful when determined error terms to apply. Recall from the 
discussion above that, we consider interaction of SPECIES and TREATMENT as whole 
plot error, and interaction among SPECIES, TREATMENT and TIME is the split-plot 
error. 
Therefore, MSE of whole-plot error is 0.03224905 and all whole-plot factors 
should be tested with using this value. Similarly, MSE of split-plot error is 0.01101595, 
and it is used to test split-plot factor. Of course, degree of freedoms should all be matched 
to tests. For example, if we want test SPECIES factor with hypothesis statement as 
𝐻0: 𝛼𝑖 = 0 𝑣𝑠. 𝐻𝑎: 𝛼𝑖 ≠ 0 
The F-ratio should be 
0.02591636
0.03224905
 and the critical value read from F distribution table 
should be with degree of freedom (1, 1). The results obviously show that SPECIES factor 
is significant. 
Checking effects factor by factor, it is clear that all term in our model are 
significant, which implies that this model is fit for our sample data. Some useful index 
can display this fitness well, residual, for example. If we can get an approximately 
horizontal residual plot, we can claim that the model we set up for specific set of data is 
fit well. Due to the original experiment design and the way we pick our sample data, the 
residuals for this model is zeros, which is possible but rare in most cases. 
Until now, we analyze our sample data precisely with a lot of details from 
different aspects and get some knowledge about split-plot design by this specific case. All 
those ideas and concerns can be applied to general split-plot case. Now, let us see the 
general split-plot looks like. 
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Figure 2.3 Normal QQ-plot of model for GENE00001 sample 
 
Table 2.1.4 ANOVA table of Split-plot model for GENE00001 Sample 
  Sources Degree of 
Freedom 
Sum of Squares 
(SS) 
Mean Square 
Error (MSE) 
Species 1 0.0259164 0.02591636 
Treatment 1 0.0002777 0.00027767 
Time 5 0.1501550 0.03003100 
Species×Treatment 1 0.0322491 0.03224905 
Species×Time 5 0.0638854 0.01277709 
Treatment×Time 5 0.1078854 0.02157709 
Species×Treatment×Time 5 0.0550798 0.01101595 
 
-3 -2 -1 0 1 2
Normal Distribution
11.1
11.2
11.3
11.4
11.5
11.6
tr
a
n
s
.o
b
s
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Section 2.2 Split-plot Design 
What is split-plot design? Split-plot experimental designs were originally 
developed by Fisher (1966) for use of in agriculture experiments. Split-plot designs are 
used when treatment factors can be categorized into two groups. Group A includes any 
factors that are relatively stable during the experiment, and Group B contains other 
relatively unstable factors. Formally speaking, Group A factors define whole-plot and 
Group B factors creates split-plots. It is not hard to notice that split plots are nested 
within whole plots. Usually, Split-plot design is nested within standard designs, such as 
Completely Randomized Design (CRD), Randomized Block Design (RBD) and Latin 
Square Design (LSD). This special structure makes Split-plot designs different from other 
standard designs. Depending on the needs of experiment, whole plot can split up multiple 
times to make multiple stages of split plots, for instance, Split-split-plot design. The 
model of Split-plot designs depends on how many stages of split plots the experiment has 
and which standard design it works with. 
Continuing using those notation from our previous example, the general split-plot 
model usually as following: 
Model 1: Yijk = µ + αi + θj + (αθ)ij + βk+ (αβ)ik + (θβ)jk  + (αθβ)ijk  + εijk 
if there were only two whole-plot factor and one split-plot factor as the case in our 
example. Similarly, all these terms in the model is defined as: µ is the grand mean; αi is 
the species effect for ith species; θj is the treatment for jth treatment; (αθ)ij  is the 
interaction effect between ith species and jth treatment applied; βk  is the time effect for kth 
time point; (αβ)ik  is the interaction effect for ith species and kth time point; (θβ)jk  is the 
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interaction effect for jth treatment and kth time point ; (αθβ)ijk is the interaction effect 
among ith species,  jth treatment and kth time point ; and εijk is the random error term . 
The assumptions are  θj   ̴  N(0, σθ2), (αθ)ij   ̴  N(0, σαθ2), (θβ)jk   ̴  N(0, σθβ2), 
(αθβ)ijk   ̴  N(0, σαθβ2), εijk   ̴ N(0, σε2) and they are mutually independent for i = 1, 2, …, I; j 
= 1, 2, …, J; k = 1, 2,…, K. General split plot model still follows the sum of squares rule: 
SSTotal = SSSpecies + SSTreatment + SSSpecies×Treatment + SSTime+ SSSpecies×Time + SSTreatment×Time + 
SSSpecies×Treatment×Time. 
Generalizing what we have already gotten from specific example above, the formulas for 
sum of squares can be calculated as  
SSTotal = ∑ ∑ ∑ (yijk − y…)
2K
k=1
J
j=1
I
i=1 ;  
SSSpecies = JK∑ (yi.. − y…)
2I
i=1 ;  
SSTreatment = IK∑ (y.j. − y…)
2J
j=1 ;  
SSSpecies×Treatment = K∑ ∑ (yij. − yi.. − y.j. + y…)
2J
j=1
I
i=1 ;  
SSTime = IJ ∑ (y..k − y…)
2K
k=1 ;  
SSSpecies×Time = J∑ ∑ (yi.k − yi.. − y..k + y…)
2K
k=1
I
i=1 ;  
SSTreatment×Time = I∑ ∑ (y.jk − y.j. − y..k + y…)
2K
k=1
J
j=1 ;  
SSSpecies×Treatment×Time = ∑ ∑ ∑ (yijk − yij. − yi.k − y.jk + yi.. + y.j. + y..k + y…)
2K
k=1
J
j=1
I
i=1 ;  
Sum of square of error term εijk is still not estimable, even for the general model. 
There are many reasons leading to this kind of estimation problem, but the typical one is 
that the error term has already been partitioned by other random effects in the model. In 
terms of this concern, we need to modify the existing model to make it standard. 
Expected Mean Squares (EMS) is an effective tool. Furthermore, for standard designs, all 
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factor effects are treated as fixed effects. Here in Split-plot design, some factors are 
random and they may be randomized in different stages. This randomization structure 
leaves a challenge to data analysis and related testing. Especially in F-tests, we have to be 
careful about the denominators since they may not be the MSE as what we have been 
used in standard design. To determine the appropriate denominators, we need to know 
how to write the EMS for all sources of variation.  
The specific method and rules about how to calculate EMS column in Table 2.2.1 
will be shown in Appendix II with i = 1, 2,…, I; j = 1, 2,…, J; k = 1, 2,…, K. This is a 
serious disadvantage for full model as Model 1 above since Mean square error plays main 
role in many kinds of testing. Combining with what we get from Table 2.2.1, σε2 + Kσαθ2 
is treated as the EMS of whole-plot error and σε2 + σαθβ2 is taken as the EMS of split-plot 
error.  
Back to the Model 1 we set up, the interaction term (αθ) ik  is often referred to as 
the whole plot error representing by εwi(j) and εwi(j) ’s   ̴  i.i.d.N(0, σW2).The usual 
assumption is that this interaction does not exist, that this term is really an estimate of the 
error within the whole plot. The term (αθβ)ijk is referred to as the split plot error 
representing by εsk(ij) and εsk(ij)’s   ̴  i.i.d. N(0, σS2). 
 Sometimes the (αβ)ik  or (θβ)jk  is also considered to be nonexistent depending on 
experiment data, and is combined with (αθβ)ijk as a part of error term εijk (Hicks et al, 
1999). It’s clear that there is a nested blocking structure: whole-plots are nested within 
blocks and split plots are nested within whole plots. This structure leads to two kinds of 
randomization. One source of randomization are the whole plots, the other is the split 
plots.  
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Table 2.2.1 EMS for Split-plot design based on GENE00001 sample 
 
 Sources d.f. 
I J K 
EMS  
F R F 
i j k 
Whole 
plot 
αi I-1 0 J K σε2 + Kσαθ2 + JK 
∑ 𝛼𝑖
2
𝑖
𝑚−1
 
θj J-1 I 1 K σε2 + IKσθ2 
(αθ)ij (I-1)(J-1) 0 1 K σε2 + Kσαθ2  
Split 
plot 
βk K-1 0 J 0 σε2 + σαθβ2 + Jσθβ2 + IJ 
∑ 𝛽𝑘
2
𝑘
𝑏−1
       
(αβ)ik 
(I-1)(K-1) 
0 J 0 σε2 + σαθβ2 + J 
∑ ∑ (𝛼𝛽)𝑖𝑗
2
𝑗𝑖
(𝑚−1)(𝑏−1)
 
(θβ)jk (J-1)(K-1) 0 1 0 σε2 + Jσθβ2                                          
(αθβ)ijk (I-1)(J-1)(K-1) 0 1 0 σε2 + σαθβ2  
εijk  1 1 1 σε2 (not estimable) 
 Total IJK-1     
 
After all this preliminary work, we can finally build up the ANOVA table for 
Model 1 is as Table 2.2.2.  
Moreover, setting up EMS table as Table 2.2.1 is extremely helpful in 
determining which effects are comparable and is valid to be tested by using hypothesis 
testing. We can compare EMS directly from Table 2.3.2. For example, EMSs of αi and 
(αθ)ij are σε2 + Kσαθ2 + JK 
∑ 𝛼𝑖
2
𝑖
𝑚−1
and σε2 + Kσαθ2, respectively. They share first two terms 
and JK 
∑ 𝛼𝑖
2
𝑖
𝑚−1
 is the only thing that makes the difference, which gives the clue that it may 
be easy to do testing for αi, and that actually, it represents the fixed effect in whole-plot 
stage. Similarly, it is not hard to notice that all fixed factors and their interaction effect 
can be easily tested by our common used F-test. There is one important aspect needs to 
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be pointed out when doing F-test for this kind of Split-plot design. We have referred to 
the term “stages “many times; it is significant to figure out which stage the effect you 
want to test located in since the “stage” determine the denominator you would use if you 
need to do an F-test. 
 
Table 2.2.2 ANOVA Table for General Split-plot Model 
Source 
of Variance 
D.F. S.S. M.S. F-Ratio 
Species I-1 SSSpecies MSSpecies MSSpecies/MSE
W 
Treatment J-1 SSTreatment   
Whole-plot error (I-1)(J-
1) 
SSE
W MSE
W  
Time K-1 SSTime
 MSTime MSTime /MSE
S 
Interaction effect 
between 
Species&Treatment 
(I-1)(K-
1) 
SSSpecies×Treatment MSSpecies×Treatment MSSpecies×Treatment 
/MSE
S 
Interaction effect 
between Treatment 
& Time 
(J-1)(K-
1) 
SSTreatment×Time MSTreatment×Time  
Split-plot error (I-1)(J-
1)(K-1) 
SSE
S MSE
S  
Total IJK-1 SSTO   
 
Based on those values in Table 2.2.2, we can do the following tests for fixed 
effects: 
𝐻0: 𝛼𝑖 = 0 𝑣𝑠. 𝐻𝑎: 𝛼𝑖 ≠ 0, by using 𝐹0 =
𝑀𝑆𝑆𝑝𝑒𝑐𝑖𝑒𝑠
𝑀𝑆𝐸
𝑊⁄  
𝐻0: 𝛽𝑘 = 0 𝑣𝑠. 𝐻𝑎: 𝛽𝑘 ≠ 0, by using 𝐹1 =
𝑀𝑆𝑇𝑖𝑚𝑒
𝑀𝑆𝐸
𝑆⁄  
𝐻0: (𝛼𝛽)𝑖𝑗 = 0 𝑣𝑠. 𝐻𝑎: (𝛼𝛽)𝑖𝑗 ≠ 0, by using 𝐹2 =
𝑀𝑆𝑆𝑝𝑒𝑐𝑖𝑒𝑠×𝑇𝑖𝑚𝑒
𝑀𝑆𝐸
𝑆⁄  
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Notice that the interaction effect between Time and Treatment is not valid to do 
an F-test and the term (αθβ)ijk is used as split-plot error for F-test. We can start to think 
about if the related terms in Model 1 is really necessary to list out separately or not. In 
statistics, it is always advantageous to use fewer parameters than more. Consider to 
modify Model 1 as this:  
Model 2: Yijk = µ + αi + θj + (αθ)ij + βk+ (αβ)ik  + εijk 
where 
αi: whole-plot factor (Species) main effect; 
θj: Treatment effect; 
(αθ)ij: whole-plot error; 
βk: split-plot factor (Time) main effect; 
(αβ)ik: interaction effect between Species and Time; 
εijk: split-plot error; 
Assumptions are hold for θj, (αθ)ij and εijk as what we stated in Model 1. This 
simplified model combines interaction effects of TIME and TREATMENT, and 
SPECIES and Treatment into εijk, and it satisfies entirely to cases if those two interaction 
effects listed above are not of the interest. The related procedures for sum of squares and 
EMS are nothing but a little bit change in whole plot terms as what we did for Model 1. 
Here, it no need to write down again. 
 
Section 2.3 Matrix Form 
For both mixed model and linear model, it is more convenient to use matrix form 
to rewrite the specific models. Matrix form formula is helpful to distinguish fixed 
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variables from random variable, comparing with regular model formulas as what we used 
previously in this chapter. For mixed model, such as split-plot model here, model allows 
the existence of both fixed and random effects. But in specific case, one of them may 
missing. Like the model we used for our sample data, all factors are fixed actually. So the 
model we generalized here don’t have random variables. In order to apply matrix notation 
to general split-plot model, let ignore the original experiment design and assume 𝜃𝑗  are 
random, and others are fixed.  
Usually, ?⃗?  represents matrix of all depending variable, such as Yijk in our model. 
𝛽  contains all fixed effect parameter vectors, for instance, 𝛼𝑖⃗⃗  ⃗, 𝛽𝑘⃗⃗⃗⃗ , 𝛼𝛽𝑖𝑘⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗   in Model 2. 𝑍  is a 
matrix filled with 1’s and 0’s depending on specific model and experiment requirement. 
?⃗?  is a matrix containing all random effect variable vectors, such as 𝜃𝑗⃗⃗⃗  , and 𝑒  is matrix of 
all error terms. The details and properties of those matrices above will be shown in 
Appendix III. Our reduced Model 2, here, can be written as 
?⃗? =  𝑋 𝛽 + 𝑍 ?⃗? + 𝑒 , where 
?⃗? =
(
 
 
 
 
 
 
 
 
𝑦111
⋮
𝑦116
𝑦121
⋮
𝑦126
𝑦211
⋮
𝑦216
𝑦221
⋮
𝑦226)
 
 
 
 
 
 
 
 
,𝑋 𝛽 =  
(
 
 
 
 
 
 
 
 
 
𝛼1
⋮
⋮
𝛽1
⋮
𝛽6
𝛼𝛽11
⋮
𝛼𝛽16
⋮
⋮
𝛼1
𝛼2
⋮
⋮
⋮
⋮
𝛼2
𝛽1
⋮
𝛽6
𝛽1
⋮
𝛽6
𝛽1
⋮
𝛽6
𝛼𝛽11
⋮
𝛼𝛽16
𝛼𝛽11
⋮
𝛼𝛽16
𝛼𝛽11
⋮
𝛼𝛽16)
 
 
 
 
 
 
 
 
 
, 𝑍 ?⃗? =
(
 
 
 
 
 
 
 
 
 
𝜃1
⋮
𝜃1
𝜃2
⋮
𝜃2
𝜃1
⋮
𝜃1
𝜃2
⋮
𝜃2)
 
 
 
 
 
 
 
 
 
, and 𝑒 =
(
 
 
 
 
 
 
 
 
𝜀111
⋮
𝜀116
𝜀121
⋮
𝜀126
𝜀211
⋮
𝜀216
𝜀221
⋮
𝜀226)
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Section 2.4 SAS for Split-plot Design 
The proper analysis of a split-plot design must account for the fact that treatments 
applied to main plots are subject to larger experimental error than those applied to 
subplots. Hence, different means squares must be used as denominators for the 
corresponding F-ratios. Also, many means comparisons of potential interest have error 
terms that are linear combinations of mean squares. While PROC GLM is useful for 
determining expected mean squares, PROC MIXED is better suited to analyze split-plot 
design. (Littell 2006) 
Based on general analysis in last section, TREATMENT is considered as random 
and Model 2 is appropriate to use here. Both PROC GLM and PROC MIXED can be 
used. In last section, EMS table (Table 2.2.1) and ANOVA table (Table 2.2.2) have been 
set up by pure structure analysis and computation. In SAS, those complex procedures can 
be done with several statements.  
Doing analysis with PROC GLM in SAS. 
proc glm; 
class species treatment time; 
model Y= species treatment species*treatment time species*time/ss3; 
test h=species e=species*treatment;            /* random treatment species*treatment/test; */ 
run; 
In PROC GLM, the TEST option “test h=species e=species*treatment” is used to 
do hypothesis for species (whole-plot factor) and it implies “species*treatment” is the 
term used as error term (whole-plot error). 
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The MSE for GENE00001 sample is shown on fourth column of Table 2.4.1. The 
result matches what we got in Section 2.1. In the Source column, the results point out 
which mean squares we need for further analysis and testing. Note that 
SPECIES×TREATMENT is listed as a source, which means the F-ratio 
𝑀𝑆𝑆𝑝𝑒𝑐𝑖𝑒𝑠
𝑀𝑆𝑆𝑝𝑒𝑐𝑖𝑒∗𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡
 
need to be computed for testing species.  
However, the F-ratio is not valid statistically in default due to the special error 
term SPECIES×TREATMENT is used. It would be better to add RANDOM statement 
here to fix this default problem. After adding RANDOM statement, SAS would output 
the correct ANOVA table. 
 
Table 2.4.1 SAS output of split-plot GENE00001 sample  
 Source DF Type III SS Mean Square F Value Pr > F 
 species 1 0.0259 0.0259 0.81 0.5331 
 treatment 1 0.0002 0.0002 0.03 0.8882 
 Error 1 0.1501 0.0300    
 species*treatment     1 0.0322 0.0322 3.43 0.1232 
 time 5 0.0638 0.0127 2.65 0.1539 
 species*time 5 0.1078 0.0215 1.22 0.4150 
 treatment*time 5 0.0550 0.0110 1.89 0.2505 
 Error: MS(Error) 5 0.0259 0.0259   
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As the conclusion made from ANOVA of standard designs, F Values indicate 
significance of all listed sources. 
Since the model contains fixed factors and random factor, it is a perfect mixed 
model. PROC MIXED is recommended. It can be done by some even simpler statements. 
proc mixed; 
class species treatment time; 
model Y= species treatment species*treatment/ddfm=satterth; 
random time species*time; 
run; 
 
In PROC MIXED procedure, only fixed terms are listed in MODEL statement 
and error terms go in the RANDOM statement. SAS don’t need to be told which error 
term to be used for testing.  
The specifics of a given design should determine whether to consider the blocking 
criterion as fixed or random, but no need here. Furthermore, more statements, such as 
CONTRAST or ESTIMATE, can be added appropriately to do further analysis as needed. 
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CHAPTER 3: SPLIT-PLOT APPLICATION IN GRAPEVINE EXPERIMENT 
 
After discussing split-plot and its related designs, we can start to work on 
RAWDATA. In this chapter, we will use split-plot design to model the grapevine 
experiment, and then we will use an appropriate model expression to examine gene 
behavior with other statistical techniques. 
 
Section 3.1 Experiment Description 
Wild grapevines represent important genetic resources. During the past century, a 
broad range of wild bunch grape species (subgenus Euvitis) form North America and East 
Asia have been used to introgress genes for pest and pathogen resistance and 
environmental tress tolerance into cultivated scion and rootstock varieties (Alleweldt et 
al, 1990). Current trends toward reducing chemical input and relying more on biological-
based disease resistance in grape cultivation makes the biological diversity of the wild 
grapevines even more relevant (Bisson et al, 2002). Understanding the molecular basis of 
this diversity will accelerate progress in harnessing the biological resources in Vitis. To 
our knowledge, genome-scale transcript level variation has not been examined in 
different Vitis species or different Vitis vinifera genotypes. An assessment of gene 
expression differences in various grapevine species will provide information about the 
role transcriptional regulation may play in phenotypic variation and adaptation. Vitis is 
highly heterozygous genus (Reisch and Pratt, 1996). At the molecular level, 
heterozygozity manifests itself in DNA sequence divergence among the different species 
and between haplotypes of V. vinifera, as evidenced by results from molecular marker-
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based genotyping, and form sequencing of allelic variants for genes and bacterial 
artificial chromosome inserts (Aradhya et al, 2003; Salmaso et al, 2004; Adam-Blondon 
et al, 2005). 
In present work, we conducted comparative mRNA abundance measurements in 
two grapevine genotypes, V. aestivalis Norton and V. vinifera Cabernet sauvignon. V. 
aestivalis Norton is a cultivated variety of North American origin. It is typical 
representative of North American grapevine species in that it is highly resistant to such 
economically important diseases as black rot, powdery mildew, and downy mildew, and 
is able to tolerate the insect pest phylloxera. V. vinifera Cabernet, on the other hand, is a 
Eurasian grapevine species which highly susceptibility to the above disease and pest. 
Furthermore, the two grapevines are distinctly different in a number of other features, 
including morphologically and physiological traits as well as fruit characteristics.  
To test the tolerance of disease for both species, V. vinifera Cabernet sauvignon 
and V. aestivalis Norton, researchers raised two sets of plants in two separate growth 
chambers, controlling all conditions the same. In each set of plants, there are 60 V. 
vinifera Cabernet sauvignon and 60 V. aestivalis Norton. To observe the plants’ behavior 
under different treatments, researchers applied inoculation with E. necator conidiospores 
to all plants raised in growth chamber A and mock inoculation was applied to those 
plants in growth chamber B. For each group containing 60 plants as we described above, 
they assigned numbers to each plants, then randomly chose 10 numbers without 
replacement and picked leaves from plants assigned with those 10 numbers to make a 
batch. An observation make on each batch yields a GeneChip. This procedure did six 
times at 0, 4, 8, 12, 24, 48 hours. On each chip, measurements for each of the 16436 
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genes were obtained. Here, each GeneChip generates a typical RNA microarray, and 
genes in the microarray are addressed by a unique identification number. We call them as 
gene ID’S. Throughout, CR1, CR2, and CR3 stands for three replicates of V. vinifera 
Cabernet sauvignon  and NR1, NR2, and NR3 are those for the three replicates of V. 
aestivalis Norton. Therefore, researchers got 2×2×6×3 = 72 observations for each of 
16436 genes. The data set for this experiment is denoted as RAWDATA. 
 
Section 3.2 Preliminary Data Modifications 
Normalization. For some data, we don’t need to normalize the observations. Why 
do we perform normalization here? As what we mentioned in section 3.1, RAWDATA is 
a Microarray data. Microarray data are noisy due to the co-existence of genuine 
biological variations (signal) and noise (Wu 2005). Signal is what we desire to use to 
distinguish one sample from another, but noise can be raised by any step of experiment, 
which may hide useful information and mislead the further data analysis, somehow. To 
make downstream analysis more precise, we have to minimize the effect of noise.  
The technique used to minimize noise here is normalization. There is variety of 
methods to normalize data. In RAWDATA, there are 72 samples due to the original 
experimental design of researchers. Here, we choose a two-step method to normalize data 
sample by sample. Firstly, using log2-transformaiton to decrease magnitudes of signals. 
Raw data may be extremely skewed. Doing log2-transformation, the magnitude of data 
decreases, which minimizes part of the noise and forces transformed data to be more 
normally distributed. For log2-transformation, 𝑙𝑜𝑔2(𝑠𝑖𝑔𝑛𝑎𝑙) is enough for most cases, 
here we prefer to modify it to be 𝑙𝑜𝑔2(𝑠𝑖𝑔𝑛𝑎𝑙 + 1) since there are zeros in RAWDATA. 
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To check if this transformation method works or not, we pick all observations of the first 
biological replicate at time point 0 of both species, CS and N, separately, as samples. In 
Figure 3.1, the histograms of raw samples are displayed. The graphs are extremely skewed, 
which implies that the noise effect would be strong and outstanding if we use raw data to 
do further analysis. 
 
 
Figure 3.1 Histograms of signals in CR1 and NR1 observed at 0 hour 
 
Figure 3.2 shows the histograms of sample data after doing log2-transformation. 
Even thoughthey are not perfectly bell-shaped, these two histograms are approximately 
normal and less skewed as what they were in Figure 3.1. By comparing Figure 3.1 and 
3.2, the benefit of log2-transformation is obvious. On the other hand, noise contributes 
the residual portion, statically. Normal QQ-plot is usually used to identify if the 
transformed variable is approximately normal. The general rule is that if the graph is 
approximately a straight li ne, the data set can be approximately described as normally 
distributed; otherwise, the residual effect of this specific data set may be noisy. In the 
graph on the left, the data is heavy-tailed normally distributed, and right graph shows the 
data is light-tailed normally distributed, which implied the log2-transformation is actually 
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improve the data quantity for further analysis. Even log2-transformed data has already 
normalized the data and made them light-tailed normally distributed, it is not standard 
enough. We need second step here. 
 
                  
Figure 3.2 Histograms of signals in log2-transformed NR1 and in log2-transformed NR1 
measured at 0 hour 
 
         
Figure 3.3 Before and after QQ-plots for CR1 at 0 hour with log2-transformation 
 
Secondly, We can try to standardize this dataset again by calculating z-score, 
𝑡𝑟𝑎𝑛𝑠𝑓𝑜𝑟𝑚𝑒𝑑 𝑑𝑎𝑡𝑎−𝑠𝑎𝑚𝑝𝑙𝑒 𝑚𝑒𝑎𝑛
𝑠𝑎𝑚𝑝𝑙𝑒 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛
 , sample by sample for all 72 samples. The importance of 
this step is to make data more standard to do analysis and avoid useless noisy effects. 
Similarly, we can show the effects of this step by histograms and Normal Q-Q plots, as 
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what they are for the first step. With the help of this two-step method, the normalized 
data is marked as THESIS in Dataset section. 
After normalizing thesis data, we can make a scatter matrix to check the 
correlation among six time points on same subject. Taking CR1 as an example, the results 
are shown in Figure 3.4. For any two time points, they are strongly correlated and there is 
not outstanding pattern in terms of time lags showing on the scatter matrix in Figure 3.4.  
This fact supports our general experiment modelling in Chapter 1 and the basic 
knowledge of correlation structure for split-plot design in Chapter 2. 
 
 
Figure 3.4 Scatter matrix for CR1 for all six time points 
 
Reshaping. Notice that in NORMDATA, the data set follows a multivariate 
structure, which is not very convenient in many analyses. To minimize trouble in further 
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analysis, we will reshape the data set into univariate structure. Using PROC IMPORT 
statement, we can import our raw data into SAS Software and reshape it. In this 
procedure, some simple statements with their options may be used here, such as PROC 
TRANSPOSE, DATA, etc. The details and commands of statements will show up in 
Appendix V. The reshaped data will replace the previous dataset named as 
NORMDATA. 
 
Section 3.3 General Modelling Procedure 
This experiment includes factors SPECIES, TREATMENTS, TIMES, and 
REPLICATES. One thing we need to notice is that the replicates here are not real 
replicates as we knew for standard designs. These three replicates are sampled from the 
same biological subjects, which is called biological replicates. And again, the 
REPLICATES factor is nested within TIMES factor.  
Considering the example in Chapter 2, we can apply similar philosophy in our 
experiment. All possible effects are main effects of SPECIES, TREATMENTS, and 
TIMES, and all their interactions, and also the nested effect of REPLICATES nested 
within TIMES effect. Mathematically, this model can be written as following 
Model 3: 𝑦𝑖𝑗𝑡𝑘 = µ + 𝛼𝑖 + 𝛽𝑗 + (𝛼𝛽)𝑖𝑗 + 𝜃𝑡 + (𝛼𝜃)𝑖𝑡 + (𝛽𝜃)𝑗𝑡 + (𝛼𝛽𝜃)𝑖𝑗𝑡 + 𝛾𝑘(𝑖𝑗𝑡) +
𝑒𝑖𝑗𝑘𝑡 
where 𝑦𝑖𝑗𝑡𝑘 denote the signal for k
th measurement at tth time point of ith species with jth 
treatment for any 𝑖 = 1, 2, 𝑗 = 1,2, 𝑡 = 1,… ,6, 𝑘 = 1,2,3; µ is the grand mean; 𝛼𝑖, 𝛽𝑗, 
(𝛼𝛽)𝑖𝑗, 𝜃𝑡, (𝛼𝜃)𝑖𝑡, (𝛽𝜃)𝑗𝑡, (𝛼𝛽𝜃)𝑖𝑗𝑡 are main and interaction effects in terms of 
SPECIES, TREATMENTS and TIMES factors; 𝛾𝑘(𝑖𝑗𝑡) represents the nested kth 
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REPLICATES effect; and 𝑒𝑖𝑗𝑘𝑡 is the random error terms following i.i.d. 𝑁(0, 𝜎
2). Other 
basic assumptions are the similar as those for the general model stated in Chapter 2. 
Recall split-plot design we discussed in Chapter 2, we always identify whole-plot 
factor, split-plot factor, and error terms in each stage, respectively. It is reasonable to 
believe that, in this case, SPECIES and TREATMENTS are set up as a 2 factorial design, 
and that they are whole-plot factors, at the same time; and TIMES can be regarded as 
split-plot factor. The biological replicates are basically nothing but repeated measures 
here. We will discuss the reason later after we check Model 3. 
Notice that, for each GeneChip, the degree of freedom on left and right sides of 
model are not equal, we can show this in Table 3.3.1. There is no doubt that the degree of 
freedom in right hand side is 71 since we have 72 signals for each GeneChip. On the right 
hand side, total degree of freedom except that for error term is 71, as well. Table 3.3.1 
suggests that error term has been partitioned into those error terms in stages of split-plot 
design. Therefore, we can consider to delete the general error term and modify our 
assumption above. The modified model is  
Model 4: 𝑦𝑖𝑗𝑡𝑘 = µ + 𝛼𝑖 + 𝛽𝑗 + (𝛼𝛽)𝑖𝑗 + 𝜃𝑡 + (𝛼𝜃)𝑖𝑡 + (𝛽𝜃)𝑗𝑡 + (𝛼𝛽𝜃)𝑖𝑗𝑡 + 𝛾𝑘(𝑖𝑗𝑡) 
Now, let us import THESIS into SAS to check rest terms. In SAS, we can use both PROC 
GLM and PROC MIXED to deal with a certain split-plot design. Once correct codes are 
written down, results from both procedure are the same. 
In this case, by using PROC GLM, we can write following statements:  
Proc glm data=NORMDATA; 
class ID SPE TR T REP; 
model Y = SPE TR SPE*TR T SPE*T T*TR SPE*TR*T REP(SPE*TR*T)/SS3; 
test h=TR E=SPE*TR; 
random SPE*TR REP(SPE*TR*T)/test; 
run; 
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Table 3.3.1 Degree of freedom for Model 3 
Source in Left Side 
Degree of 
Freedom 
Sources in Right side 
Degree of 
Freedom 
𝑦𝑖𝑗𝑡𝑘 72-1 
𝛼𝑖 2-1 
𝛽𝑗 2-1 
(𝛼𝛽)𝑖𝑗 (2-1)(2-1) 
𝜃𝑡 6-1 
(𝛼𝜃)𝑖𝑡 (2-1)(5-1) 
(𝛽𝜃)𝑗𝑡 (2-1)(5-1) 
(𝛼𝛽𝜃)𝑖𝑗𝑡 (2-1)(2-1)(5-1) 
𝛾𝑘(𝑖𝑗𝑡) 2×2×6×(3-1) 
𝑒𝑖𝑗𝑘𝑡 ? 
Total 71 Total 71+? 
 
The first output getting from these statements is the EMS table (Table 3.3.2) for 
each term in model, which is exactly same as what we did in Chapter 2 and in Appendix 
II. Noting that we only used the data of the first gene. We discussed about how to use 
EMS table to determine the stage errors. See the results in EMS column of Table 3.3.2, it 
is clear now that SPE*TR (interaction effect of SPECIES and TREATMENTS) is the 
whole plot error and REP (SPE*TR*T), REPLICATES effect nested within SPECIES, 
TREATMENTS and TIMES factors, is the split-plot error. One thing we need to pay 
special attention here is if we take all genes’ observations into consideration the 
coefficients would be huge since SAS takes gene ID as a variable in default. This is not 
reasonable in experiment. If only those observations of one certain gene (such as GENE 
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00001) were concerned, the results would exactly the same as what we calculated in 
Chapter 2. And our assumption is whole-plot error follows i.i.d. 𝑁(0, 𝜎𝑤
2) and split-plot 
error follows i.i.d. 𝑁(0, 𝜎𝑠
2), and they are mutually independent. 
 
Table 3.3.2 SAS output of EMS for model in Model 4 
Source Type III Expected Mean Square 
SPE Var(Error) + Var(REP(SPE*TR*T)) + 18 Var(SPE*TR) + 
Q(SPE,SPE*T SPE*TR*T,) 
TR Var(Error) + Var(REP(SPE*TR*T)) + 18 Var(SPE*TR) + 
Q(TR,TR*T,SPE*TR*T) 
SPE*TR Var(Error) + Var(REP(SPE*TR*T)) + 18 Var(SPE*TR) + 
Q(SPE*TR*T) 
T Var(Error) + Var(REP(SPE*TR*T)) + 
Q(T,SPE*T,TR*T,SPE*TR*T) 
SPE*T Var(Error) + Var(REP(SPE*TR*T)) + Q(SPE*T,SPE*TR*T) 
TR*T Var(Error) + Var(REP(SPE*TR*T)) + Q(TR*T,SPE*TR*T) 
REP(SPE*TR*T) Var(Error) + Var(REP(SPE*TR*T)) 
 
Another output is the ANOVA table (Table 3.3.3), which directly implies that all 
terms of model 4 are significant, since all p-values are extremely small.  
When using PROC GLM for split-plot design, we have noticed that only one error 
term (usually, the error in the very last stage) is used to calculate all F values in the 
default, so only those F values of effects in very last stage is correct in default results, for 
instance, T, SPE*T, and TR*T in Table 3.3.3. We need to tell SAS which error term we 
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want to use when calculating F value for specific effect. TEST option here is add to 
specify which one to do hypothesis testing and which stage error to use. 
 
Table 3.3.3 ANOVA for model in model 4 by using PROC GLM 
 
 
 
 
    
 
 
 
 
Noting that random term, REP (SPE*TR*T) here, shows neither in MODEL 
statement nor in RANDOM statement. In this experiment, we can write code as below in 
SAS and output shows in Table 3.3.4. 
Proc mixed data=NORMDATA method=ml; 
class ID SPE TR T REP;  
model Y = SPE TR SPE*TR T SPE*T T*TR; 
random SPE*TR;  
run; 
 
As we said above, the results should be the same in both procedures. Even though 
some p-values in PROC MIXED procedure don’t show up appropriately and some p-
values in PROC GLM is not even correct in default, we can still see the results for T, 
SPE*T, and TR*T are the same, and we have ensured these values are correct in default. 
Source DF Type III SS Mean Square F Value Pr > F 
SPE 1 16517.86240 16517.86240 1868.59 <.0001 
TR 1 350.21838 350.21838 39.62 <.0001 
SPE*TR 1 585.31561 585.31561 66.21 <.0001 
T 5 991.62840 198.32568 22.44 <.0001 
SPE*T 5 171.16638 34.23328 3.87 0.0016 
TR*T 5 218.52642 43.70528 4.94 0.0002 
REP(SPE*TR*T) 53 6225.59124 117.46399 13.29 <.0001 
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That is enough to prove both procedure function well and the model in model 4 is 
appropriate tested by our dataset. 
 
Table 3.3.4 ANOVA table for model in model 4 by using PROC MIXED 
 
 
 
 
 
 
 
 
 
 
Section 3.4 Computation of Gene-Specific Significance Models 
After finishing general modelling, we need to focus on the main purpose of our 
experiment, which is to test which gene(s) expression is/are significantly different from 
others in terms of TREATMENTS. In order to reach this goal, we need to apply our 
model in model 4 to each GeneChip and observe the results one by one. First of all, we 
need to sort our data NORMDATA in SAS to perform mixed model ANOVA for 
individual genes. In SAS, SORT procedure can be applied here. 
Proc sort data=NORMDATA; 
by ID SPE TR T REP; 
run; 
Type 3 Tests of Fixed Effects 
Effect Num DF Den DF F Value Pr > F 
SPE 1 0 1867.46 . 
TR 1 0 39.60 . 
SPE*TR 1 0 66.18 . 
T 5 12E5 22.42 <.0001 
SPE*T 5 12E5 3.87 0.0016 
TR*T 5 12E5 4.94 0.0002 
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Under this procedure, our data NORMDATA are sorted by ID, then by SPECIES, 
then by TREATMENTS, etc. For our purpose, only ID one really matters, as this ensures 
that all of the values for each clone are grouped into contiguous block (Gibson and 
Wolfinger 2004). And then we can perform gene-specific ANOVA. Typing the following 
text into the editor pane of SAS and submit it: 
ods exclude all; 
ods noresults; 
proc mixed data = NORMDATA; 
by ID; 
class ID SPE TR T REP; 
model Y=SPE TR SPE*TR T SPE*T T*TR SPE*TR*T/ outp= NormData1; 
random REP(SPE*TR*T); 
lsmeans SPE TR SPE*TR T SPE*T T*TR SPE*TR*T/diff; 
ods output covparms=COVparms tests3=Tests3 lsmeans=lsms diffs=Diffs; 
run; 
ods exclude none; 
ods results; 
 
By running this set of statements, SAS would automatically apply model to 16436 
genes one by one and provide ANOVA table for each Gene ID in Test3 results. Test3 
results are shown in Table 3.4.1. In this set of ANOVA tables, only items we concern 
about are the p-values for TREATMENTS effect, because it implies the significance of 
TREATMENTS effect. Instead of showing the huge amount of results here, we pick the 
results of 10 genes in terms of the p-values of TREATMENTS effect to explain.  
In column ProbF, we can notice that values for all genes except first and fourth 
ones are relatively large, over 0.1. For first gene, p-value = 0.0201, which implies this 
gene expresses differently under treatments if we take 0.05 as level of significance. 
Similarly, for the fourth gene, it p-value is 0.0677. It is a little bit higher than 0.05, but it 
is possible to consider it is differently expressed if a higher biological significant level is 
chosen. On the other hand, for the rest of eight genes, their p-value is considered to be 
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large in most cases, statistically. We can conclude that their TREATMENTS effects are 
not significant, and furthermore, their gene expressions don’t change much under 
different treatments in this experiment. Depending on the choice of significance levels, 
gene expression can be easily determined from the results as Table 3.3.1. This analysis 
can be generalized to all 16436 genes to check if their TREATMENTS effects are 
significant or not. If yes, we can pay special attention to it in further research to explore 
their special properties.  
Table 3.4.1 Brief ANOVA for first 10 genes in terms of TREATMENTS effect 
Obs ID Effect NumDF DenDF FValue ProbF 
1 GENE00001 TR 1 48 5.78 0.0201 
2 GENE00002 TR 1 48 0.09 0.7659 
3 GENE00003 TR 1 48 1.61 0.2107 
4 GENE00004 TR 1 48 3.50 0.0677 
5 GENE00005 TR 1 48 0.21 0.6461 
6 GENE00006 TR 1 48 0.32 0.5733 
7 GENE00007 TR 1 48 0.92 0.3418 
8 GENE00008 TR 1 48 2.49 0.1211 
9 GENE00009 TR 1 48 0.10 0.7537 
10 GENE00010 TR 1 48 2.49 0.1213 
 
 
Section 3.5 Further Concern 
In previous sections, we did analysis by modelling data as split-plot. The results 
are quite clear in procedures; however, we also noticed that there are many potential 
properties ignored when using split-plot. For example, the split-plot design never 
considers the possible reason why a researcher did measurements at six different time 
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points and the possible biological pattern implied by measurements. Actually, we can do 
some brief analysis based on time. Recall that in Figure 3.4, it is no problem that 
correlation between any two time points are extremely high; however, we may have 
already noticed that the plot is slightly spread out as the time difference increases at first 
four time points, and that the shape of scatter plots are similar among 0 hour, 24 hour, 
and 48 hours. Those can be concluded as an obscure pattern saying that the correlation 
decreases slightly with the increasing of time lag among the first three time points and 
that the correlation among 0 hour, 24 hour, and 48 hours are relatively stable. This pattern 
can be clearly displayed by covariance correlation table. Randomly pick all observations 
of CS with MOC applied, the correlation table is given by S-plus in Table 3.5.1. 
 
Table 3.5.1 Correlation table for CS under treatment MOC at six time points 
 0 hour 4 hours 8 hours 12 hours 24 hours 48 hours 
0 hour 1.0000000      
4 hours 0.9787216 1.0000000     
8 hours 0.9397674 0.9720687 1.0000000    
12 hours 0.9308847 0.9418207 0.9682751 1.0000000   
24  hours 0.9667132 0.9626963 0.9230444 0.9029759 1.0000000  
48  hours 0.9462432 0.9430237 0.9010002 0.8883521 0.9822352 1.0000000 
 
Due to the property of correlation between two variables, values in cells are 
symmetric. For instance, correlation between 4 hours and 24 hours is exactly same as 
what it is for 24 hours and 4 hours. In the second column (0 hour column) of Table 3.4.1, 
we can see the correlation declines in time interval [0, 12], from 1.0000000 to 0.9308847; 
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at the same time, corr(0 hour, 24 hours) raised up to 0.9667132 and corr(0 hour, 48 
hours) = 0.9462432. This fact may imply a cycling biological pattern, such as the diurnal 
cycle. 
In split-plot design, this special pattern is totally ignored, since split-plot design 
has a symmetric component assumption about measurements made from same subjects. 
To make full use of this new potential information, more precise models, such as 
repeated-measures design, can be considered if current results could not satisfy the 
researchers’ requirements. Briefly, the repeated measurement design provides more 
flexibility on component assumption on the measurements made from the same 
experiment units. Next, we will spend a chapter to discuss repeated measurement 
experiment design. 
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CHAPTER 4: REPEATED-MEASURES DESIGN  
 
In the previous chapter, we discussed Split-plot Design. There is another 
commonly used experimental design with some special property and advantages. It is the 
Repeated Measurements Design. In this chapter, we will introduce knowledge related to 
Repeated Measurements Design and compare it with Split-plot Design.  
 
Section 4.1: Background 
In recent decades, researches have been expanding from natural sciences to social 
and behavioral sciences. People are frequently chosen to be subjects of research. A good 
example is doing survey by questionnaire.  
The researchers design different questions for different group of people based on 
their different occupations, regions, levels of education, and so on. And it is rarely that 
they pick a single person in each group to finish their survey because it would waste the 
effort of researcher developer. Multiple people would be randomly picked. This kind of 
research design implies their potential concerns, which are people in same group share 
some common parts and also the difference among people in same group can make the 
research more precise.   
The example above demonstrates that selecting multiple people may be useful to 
improve research somehow. But how does this kind of design help? Doing survey can be 
looked as a kind of experiment. And then, we can review this survey statistically. 
Different versions of questionnaires are similar to different kinds of treatments applied in 
experiment. We will show details in following sections in this chapter. 
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Section 4.2 Statistical Introduction 
In the example of last section, the group we described in last section are typically 
called as experimental units, or subjects in statistics. Researchers apply each treatment to 
each subject and get multiple observations (different results from different people in same 
group) for each subject. Such a design is called a Repeated Measures Design 
(Montgomery, 1997). Repeated measures refers to multiple measures on the same 
experimental unit. Usually, repeated measures are made over time, but they can be over 
space. A very common situation is for treatments to be applied to experimental units in a 
completely randomized design. Then measurements are made at several different times 
(Littell, et al. 2002). Let’s consider the measurements made in a sequence of time point. 
Those observations get from same subjects should be related and dependent since they 
share some common properties from the subject. And also, observations which are 
measured closer in time should have a stronger impact than those get measured far away 
in time. These abstract thinking can be concluded as the variance and covariance 
structure, which is exactly the special property for Repeated measures design.  
 
Section 4.3 Model 
We mentioned variance and covariance structure in previous section, here we will 
explain it more specifically with example and its model. For instance, a medical 
institution plans to examine the effects of n drugs for insomnia patients. n drugs are 
assigned to n groups each randomly. Researchers then measure the time taking to fall 
asleep daily in following t successive days for patients with the help of each kind of 
drugs.  
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The experiment units, or subjects, are patients here. Drugs are considered to be 
treatments. It’s clear that the repeated measures are taking by times. The effects we can 
conclude here are DRUG, TIME, DRUG*TIME. The model for this example is  
𝑦𝑖𝑗𝑘 = µ + 𝛼𝑖 + 𝛽𝑘 + (𝛼𝛽)𝑖𝑘 + 𝑒𝑖𝑗𝑘 
where  
µ is the overall mean; 𝛼𝑖, 𝛽𝑗, (𝛼𝛽)𝑖𝑗 are 𝑖
𝑡ℎ drug effect, 𝑘𝑡ℎ time effect and their 
interaction effect, respectively; 𝑒𝑖𝑗𝑘’s are random error for 𝑗
𝑡ℎ patient taking 𝑖𝑡ℎ drug at 
 𝑘𝑡ℎ day. 
Directly from the form of model, two questions are raised: 
1. Different patients should make difference; however, no main or even interaction 
effect involving patient effect. How could this model explain the variability of 
different patient? 
 
2. This model is exactly the same with certain kind of 2 factorial design. Why do we 
say this model works for Repeated measures design? 
These two question can be answered by the special properties of error term 𝑒𝑖𝑗𝑘. 
These properties are called variance and covariance structure of 𝑒𝑖𝑗𝑘. Since time factor is 
not randomly assigned, we cannot assume error terms are independent generally as what 
we do for other standard design, or even not as Split-plot design.  
 
Section 4.4 Variance and Covariance Structure 
As what we said in section 2 of this chapter, measurements made on same 
subjects share common property from subject and measurements influent others stronger 
when they are closer in time, in space, or in condition. Formally speaking, those two 
conclusions are two aspects of covariance structure in errors: 
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1. Measurements made from same subject are stronger, positively in most cases, 
correlated than those made from different subjects.  (Sometimes, this aspect is 
called as between-subject variation) 
 
2. Measurements made closer in time, in space, or under conditions are highly 
correlated than those made far apart. Correlation can follow various structure, it is 
not always linear.  
Due to the importance of covariance structure for repeated measures design, this 
structure has to be considered and specified in doing statistical analysis technique. Many 
methods have been developed to deal with covariance structure for repeated measures 
design. We introduce three general methods. 
Univariate ANOVA. This approach is also known as split-plot in time ANOVA. 
Why so? Univariate ANOVA treats repeated measures data same as split-plot data. 
Subjects and time factors are matching with whole plot units and split plot factors, which 
means only the first aspect of covariance structure is considered in analysis. It’s not 
always appropriate for repeated measures data, but if correlations between measures on 
the same subject are the same regardless of time proximity, then this approach is a 
perfectly good method of analysis (Littell, et al. 2006). 
Analysis of Contrasts. Instead of doing analysis on data directly, analysis of 
contrasts analyzes linear combinations of data on each subject. In this approach, we 
introduce regression concept by considering measurements on same subject are regressed 
on time. The slopes of these regression line are treated as the effects of time on each 
subject. By doing analysis of these slopes, we can analyze the effects of treatments on 
these time effects. Since the covariance structure is not considered here, this approach is 
not optimal. 
Mixed-model Methodology. This approach contains two steps. The first step is 
estimating covariance structure. Second is substituting estimated covariance structure into 
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the model. And then we can use (generalized) least-squared method to assess treatment 
and time effects. However, estimation of covariance structure is not an easy job to do. 
With the development of statistical programs, this complex estimation can be done by 
computer software, for instance, PROC MIXED in SAS. 
For the convenience of writing down, matrix forms are introduced in almost all 
aspects of statistics. Matrix form is applied to statistical models. Details are shown in 
Appendix III.  In terms of matrix form, modelling covariance structure is finding the form 
of G and 𝑹𝒊𝒋, portions of R that corresponds to an individual subject. There are many 
candidate covariance structures to choose from.  
Simple covariance structure is as the name implies, which is the simplest 
structure. It assumes all measurements (observations) are independent no matter they are 
made on same subjects or not, and variance of measurements are homogenous. Then the 
correlation function is 0 in this case. Backing to example in section 3, simple covariance 
structure as 
𝑐𝑜𝑣(𝑦𝑖𝑗𝑘, 𝑦𝑖𝑗𝑙) = 0 𝑖𝑓 𝑘 ≠ 𝑙 𝑎𝑛𝑑 𝑣𝑎𝑟(𝑦𝑖𝑗𝑘) = 𝜎𝑆𝐼𝑀
2 
Recall the matrix form in Appendix III,𝐆 = 𝟎 and 𝑹𝒊𝒋 = 𝜎𝑆𝐼𝑀
2𝑰, where I is an 
identity matrix. 
Notice that, under simple structure, there is an independence assumption, which 
leads this structure not realistic for repeated measures data most of time. 
Compound symmetric structure specifies repeated measurements on same subject 
share same covariance and each has same variance, representing by 𝜎𝐶𝑆,𝑏
2 and 𝜎𝐶𝑆,𝑏
2 +
𝜎𝐶𝑆,𝑤
2, respectively. Because of this kind of representation, compound symmetric 
structure is also called variance components structure. The correlation function 
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is
𝜎𝐶𝑆,𝑏
2
𝜎𝐶𝑆,𝑏2+𝜎𝐶𝑆,𝑤2
. Correlation here is free of time difference and it is nonnegative, in other 
words, any pair of measurements on same subjects should have same nonnegative 
correlation. In matrix form, it can be shown as  
𝐆 = 𝜎𝐶𝑆,𝑏
2𝑰 𝑎𝑛𝑑 𝑹𝒊𝒋 = 𝜎𝐶𝑆,𝑤
2𝑰, 𝑜𝑟 
𝐆 = 𝟎 𝑎𝑛𝑑 𝑹𝒊𝒋 = 𝜎𝐶𝑆,𝑤
2𝑰 + 𝜎𝐶𝑆,𝑏
2𝑱 
Depend on certain cases, people can choose why to define their matrices. 
Similar to the definition of AR(1) in time series, this covariance structure assumes 
all measurements have the same variance and the covariance between measurements on 
same subjects has a regressive relation; specifically speaking, covariance decreases with 
the increasing of time difference. 
𝑐𝑜𝑣(𝑦𝑖𝑗𝑘, 𝑦𝑖𝑗𝑙) = 𝜎𝐴𝑅(1)
2𝜌𝐴𝑅(1)
|𝑘−𝑙|, 𝑎𝑛𝑑 
𝐆 = 𝟎 𝑎𝑛𝑑 𝑹𝒊𝒋 = 𝜎𝐴𝑅(1)
2𝜌𝐴𝑅(1)
|𝑘−𝑙| 
Consider the second aspect of the covariance structure for repeated measures 
design, AR(1) meets the requirement much better than first two, and it, perhaps, is the 
most commonly used structure.  
The only difference between this structure and last one is variance partitions into 
within-subject and between-subjects due to the random effect adding in to subjects. So 
the variance and covariance now look as following  
𝑣𝑎𝑟(𝑦𝑖𝑗𝑘) = 𝜎AR(1)+RE,b
2 + 𝜎AR(1)+RE,w
2 𝑎𝑛𝑑  
𝑐𝑜𝑟𝑟AR(1)+RE =
𝜎AR(1)+RE,b
2 + 𝜎AR(1)+RE,w
2𝜌𝐴𝑅(1)+𝑅𝐸
|𝑘−𝑙|
𝜎AR(1)+RE,b2 + 𝜎AR(1)+RE,w2
 
In terms of matrix, 𝐆 = 𝜎AR(1)+RE,b
2𝑰 𝑎𝑛𝑑 𝑹𝒊𝒋 = 𝜎𝐴𝑅(1)
2𝜌𝐴𝑅(1)+𝑅𝐸
|𝑘−𝑙| 
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Toeplitz structure, sometimes called ‘banded’, specifies that covariance depends 
only on time difference, but not as a mathematical function with a smaller number of 
parameters. The correlation function is 
𝜎𝑇𝑂𝐸𝑃,|𝑑𝑖𝑓𝑓|
𝜎𝑇𝑂𝐸𝑃2
 and 𝐆 = 𝟎 and R is a matrix with 
𝜎𝑇𝑂𝐸𝑃
2 on the main diagonal and 𝜎𝑇𝑂𝐸𝑃,|𝑑𝑖𝑓𝑓| on a sub-diagonal |𝑘 − 𝑙|, where 𝑘 is the 
row number and 𝑙 is the column number. (Littell, et al., 2000) 
The unstructured structure specifies no patterns generally. It needs a very large 
amount of parameter and requires a large data set to make result precisely. 
AR (1) and TOEP are both widely used handing covariance structure issues for 
repeated measures data. However, they have an outstanding limit; that is, both those 
structures make sense when time points (or spaces) are equally spaced.  
In reality, time points are not always evenly assigned in experiment. We need 
covariance structure for this general case. Ante-dependence model with order 1 can 
handle this problem. In this case, R is a matrix with 𝜎𝑘
2in main diagonal and 
𝜎1𝜎𝑘∏ 𝜌𝑖
𝑘−1
𝑖=1  on off-diagonal, where k is the number of measurements. 
There are many other covariance structures useful in unequal spaced cases. The 
most common of these are SP (POW) (spatial power law), SP (GAU) (gaussian), and SP 
(SPH) (spherical). (Littell, et al. 2000)  
For example, SP (POW) provides a generalization of the AR (1) structure for 
unequal spaced data. It produces cov(𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗𝑙) = 𝜎𝑆𝑃(𝑃𝑂𝑊)
2𝜌|𝑘−𝑙| and ρ is an 
autoregressive parameter with |𝜌| < 1. 
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Section 4.5 Advantages and Disadvantages of Repeated-measures Design 
A repeated measures design is using the same participants for all of your 
experimental conditions (Field, 2011).  This is in contrast to other standard designs. A 
benefit of using repeated measures (using the same participants for both manipulations) is 
it allows the researcher to exclude the effects of individual differences that could occur if 
two different people were used instead (Howitt & Cramer, 2011). Each subject serves as 
own control so that between-subject effects get isolated, which makes the analysis focus 
on treatment effects more precisely.  
Recall what we said in section 1 of this chapter, repeated measures designs ask 
fewer subjects than other related independent groups designs; this fact makes repeated 
measures designs more efficient and convenient. Apart from all advantages above, 
repeated measures design can detect the effects of all independent variable, no matter 
they are significant or relatively small, so we can say repeated measures is more sensitive 
than other standard designs. 
Repeated measures designs also have their limits. Generally, these limits can be 
conclude as following three aspects: 
1. Carry-over Effect. It happens when a treatment is applied before the effects of 
previous one has worn off. So researchers need sufficient long time between 
treatments. 
 
2. Latent Effect. If two treatments were relatively related, the later one may 
activate the effects of previous treatment. This can mislead the results and 
conclusions of experiment. 
 
3. Learning Effect. Since this kind of design use same subject for all conditions 
(treatments), subject can improve, or get worse, at each time of measurements, 
especially when subjects are people. This effect can change the conclusions 
made for treatments. 
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Section 4.6 Repeated Measures Designs and Split-plot Designs 
In section 4, we notice that the first aspect of covariance structure is the similarity 
to the assumption made for measurements on same whole plot in Split-plot design, which 
implies Split-plot design and repeated measures design are comparable. The only feature 
to make them different is the second aspect of covariance. In repeated measures design, 
we take repeated measurements over time for each subject. These subjects can be looked 
on as whole plots. So if all these repeated measurements are equally correlated over time, 
then time effect is nothing but a sub-plot effect. Actually, this case is following the 
Univariate ANOVA approach in Section 4. 
The ANOVA table for a split-plot design can be used as an approximation 
ANOVA to its related repeated measurement. The thing we need to do is we need to 
modify the degrees of freedom of repeated factors and interactions involving them.  This 
new degree of freedoms are called Conservative degree of freedom. The specific method 
is replace the degrees of freedom of repeated factors by 1’s. For instance, consider Table 
2 in Chapter 1. If we use it as the approximate ANOVA table for related repeated 
measures design. Here βk can be considered as the repeated factor effect for its related 
repeated measures design. W can see conservative d.f.’s as what are shown in Table 
4.5.1. 
And then we can use Conservative d.f. column in Table 4.5.1 to do tests for 
effects. If these two designs give different results, modifying degree of freedom, using 
REPEATED statement, or testing assumptions can be used to solve some cases, but not 
all. This issue is beyond the scope here. However, if repeated measurements are 
significant when conservative d.f. are used, conclusions from both designs are sound. 
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Table 4.5.1 Approximate ANOVA of repeated measurements analysis 
 Sources d.f. 
Conservative 
d.f. 
Whole plot 
αi m-1 m-1 
θj n-1 n-1 
(αθ)ij (m-1)(n-1) (m-1)(n-1) 
Split plot 
βk b-1 1 
(αβ)ik (m-1)(b-1) m-1 
(θβ)jk (n-1)(b-1) n-1 
(αθβ)ijk (m-1)(n-1)(b-1) (m-1)(n-1) 
εijk   
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CHAPTER 5: SUMMARY 
 
There is no simple answer to say which design fits the experiment best. Based on 
different biological requirements, different designs would be chosen. Split-plot design is 
convenient in having to grow only a limited number of plants and saves time and funds, 
and it can satisfy most research goals. However, repeated-measures design provides 
flexibility of component structure, which gives us a chance to taking covariance between 
time points into account and supports our cyclic pattern assumption. There must be more 
designs can fit the data and experiment better, so the research based on this set of data 
will last long. 
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GLOSSARY 
 
Analysis of variance (ANOVA): a procedure for constructing statistical tests by 
partitioning the total variance into different sources. 
Biological replicates: biological samples obtained in replicate form independent 
sources representing the same condition.   
Decomposition: separation of a complex variance term in an ANOVA model into 
its components, which is attributable to all effects and their interactions. 
Degree of freedom: the number of levels that can vary freely in a term of an 
ANOVA model. It is typically one less than the number of levels in the factor. 
Error variation: the variation associated with an estimated quantity. It is the 
square of the standard error and in commonly used to assess the accuracy of estimation. 
Fixed effect: a term in an ANOVA model for which the levels are going to be 
repeated exactly if the experiment is repeated. We are generally interested in the mean 
values associated with levels of a fixed effect.  
Gene expression profiling: the monitoring of differences in the level of 
expression of thousands of individual genes across a series of treatments. 
Mixed-model ANOVA: an ANOVA model in which some terms are treated as 
random effects and others as fixed effects. In a mixed model there may be multiple 
sources of random variation. 
Normalization: the process of removing certain systematic biased form 
microarray data. 
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Null hypothesis: a hypothesis for which the effects of interest are assumed to be 
absent. Commonly used as a basis for constructing statistical tests. 
Power: the probability that a real effect can be identified by a statistical test. It is 
one minus the type II error probability. 
P-value: a measure of the evidence against the null hypothesis in a statistical test. 
It is the probability of the occurrence of a test statistic equal to, or more extreme than, the 
observed value under the assumption that the null hypothesis is true. 
Random effect: a term in ANOVA model for which the levels represent a sample 
from a population of levels. In a replicated experiment the same values will not repeat. 
We are generally interested in the variability associated with a random effect. 
Residual: the difference between an observed data value and its expectation as 
predicted by a model. It is the lowest-level term in ANOVA model, denoted as 𝑒𝑖. 
Residual sums of squares: the sum of all the residuals squared. It is a measure of 
the total discrepancy between a model and the observed data. 
Restricted maximum likelihood: a numerical method for estimating variance 
components in a mixed ANOVA model. 
Significance level: the size of p-value that is regarded as providing sufficient 
evidence against a null hypothesis. If the p-value falls below the significance level, the 
null hypothesis is rejected. 
Technical replicates: multiple RNA samples obtained from the same biological 
source. 
Type I error: the event of rejecting a null hypothesis when it is true. 
Type II error: the event of failing to reject a null hypothesis when it is false. 
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APPENDICES 
 
Appendix I Deriving Sum of Squares  
Step 1: Decomposition  
𝑦𝑖𝑗𝑘 − 𝑦… = (𝑦𝑖.. − 𝑦…) + (𝑦.𝑗. − 𝑦…) + (𝑦𝑖𝑗. − 𝑦𝑖.. − 𝑦.𝑗. + 𝑦…) + (𝑦..𝑘 − 𝑦…)
+ (𝑦𝑖.𝑘 − 𝑦𝑖.. − 𝑦..𝑘 + 𝑦…) + (𝑦.𝑗𝑘 − 𝑦.𝑗. − 𝑦..𝑘 + 𝑦…) + (𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗. − 𝑦𝑖.𝑘
− 𝑦.𝑗𝑘 + 𝑦𝑖.. + 𝑦.𝑗. + 𝑦..𝑘 + 𝑦…) 
When doing decomposition for each term in model, we need to check if left and 
right sides are equal after cancellation. Left and right sides are equal for our case. At the 
same time, left side is the estimate of µ, and portions in right side are estimates for αi , θj , 
(αθ)ij , βk, (αβ)ik , (θβ)jk , (αθβ)ijk, respectively.  
Step 2: Adding Summation Symbol for Both Sides 
∑∑∑(𝑦𝑖𝑗𝑘 − 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
=∑∑∑[(𝑦𝑖.. − 𝑦…) + (𝑦.𝑗. − 𝑦…) + (𝑦𝑖𝑗. − 𝑦𝑖.. − 𝑦.𝑗. + 𝑦…)
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+ (𝑦..𝑘 − 𝑦…) + (𝑦𝑖.𝑘 − 𝑦𝑖.. − 𝑦..𝑘 + 𝑦…) + (𝑦.𝑗𝑘 − 𝑦.𝑗. − 𝑦..𝑘 + 𝑦…)
+ (𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗. − 𝑦𝑖.𝑘 − 𝑦.𝑗𝑘 + 𝑦𝑖.. + 𝑦.𝑗. + 𝑦..𝑘 + 𝑦…)]
2 
Sum of squares on both sides are equal naturally since roots for both sides equals 
from step 1. 
Step 3: Simplify right side 
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∑∑∑[(𝑦𝑖.. − 𝑦…) + (𝑦.𝑗. − 𝑦…) + (𝑦𝑖𝑗. − 𝑦𝑖.. − 𝑦.𝑗. + 𝑦…) + (𝑦..𝑘 − 𝑦…)
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+ (𝑦𝑖.𝑘 − 𝑦𝑖.. − 𝑦..𝑘 + 𝑦…) + (𝑦.𝑗𝑘 − 𝑦.𝑗. − 𝑦..𝑘 + 𝑦…)
+ (𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗. − 𝑦𝑖.𝑘 − 𝑦.𝑗𝑘 + 𝑦𝑖.. + 𝑦.𝑗. + 𝑦..𝑘 + 𝑦…)]
2
 
=∑∑∑(𝑦𝑖.. − 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+∑∑∑(𝑦.𝑗. − 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+∑∑∑(𝑦𝑖𝑗. − 𝑦𝑖.. − 𝑦.𝑗. + 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+∑∑∑(𝑦..𝑘 − 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+∑∑∑(𝑦𝑖.𝑘 − 𝑦𝑖.. − 𝑦..𝑘 + 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+∑∑∑(𝑦.𝑗𝑘 − 𝑦.𝑗. − 𝑦..𝑘 + 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+∑∑∑(𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗. − 𝑦𝑖.𝑘 − 𝑦.𝑗𝑘 + 𝑦𝑖.. + 𝑦.𝑗. + 𝑦..𝑘 + 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
 
All interaction terms are equal to zero based on our assumption for model. Taking 
first two term of right side in step 1 as an example. 
∑∑∑((𝑦𝑖.. − 𝑦…) + (𝑦.𝑗. − 𝑦…))
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
=∑∑∑(𝑦𝑖.. − 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+∑∑∑(𝑦𝑖.. − 𝑦…)(𝑦.𝑗. − 𝑦…)
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+∑∑∑(𝑦.𝑗. − 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
 
      = ∑∑∑(𝑦𝑖.. − 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+∑∑∑(𝛼𝑖)(𝜃𝑗)
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+∑∑∑(𝑦.𝑗. − 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
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      = ∑∑∑(𝑦𝑖.. − 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+ 𝑏∑ 𝛼𝑖
𝑚
𝑖=1
∑ 𝜃𝑗
𝑛
𝑗=1
+∑∑∑(𝑦.𝑗. − 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
 
                                = ∑∑∑(𝑦𝑖.. − 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
+∑∑∑(𝑦.𝑗. − 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
 
                                = 𝑛𝑏∑(𝑦𝑖.. − 𝑦…)
2
𝑚
𝑖=1
+𝑚𝑏∑(𝑦.𝑗. − 𝑦…)
2
𝑛
𝑗=1
 
For rest terms on right side, similar way and assumption can be applied to. After 
simplification, we can get following result for right side of equation. 
Right side 
= 𝑛𝑏∑(𝑦𝑖.. − 𝑦…)
2
𝑚
𝑖=1
+𝑚𝑏∑(𝑦.𝑗. − 𝑦…)
2
𝑛
𝑗=1
+ 𝑏∑∑(𝑦𝑖𝑗. − 𝑦𝑖.. − 𝑦.𝑗. + 𝑦…)
2
𝑛
𝑗=1
𝑚
𝑖=1
+𝑚𝑛∑(𝑦..𝑘 − 𝑦…)
2
𝑏
𝑘=1
+ 𝑛∑∑(𝑦𝑖.𝑘 − 𝑦𝑖.. − 𝑦..𝑘 + 𝑦…)
2
𝑏
𝑘=1
𝑚
𝑖=1
+𝑚∑∑(𝑦.𝑗𝑘 − 𝑦.𝑗. − 𝑦..𝑘 + 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
+∑∑∑(𝑦𝑖𝑗𝑘 − 𝑦𝑖𝑗. − 𝑦𝑖.𝑘 − 𝑦.𝑗𝑘 + 𝑦𝑖.. + 𝑦.𝑗. + 𝑦..𝑘 + 𝑦…)
2
𝑏
𝑘=1
𝑛
𝑗=1
𝑚
𝑖=1
 
Step 4: Checking Degree of Freedom 
Listing out degree of freedom for each corresponding term in the same order as 
what step 1 shows. With basic algebra, it is easy to check left and right side have same 
degree of freedom 
mnb-1 = (m-1) + (n-1) + (m-1) (n-1) + (b-1) + (m-1) (b-1) + (n-1) (b-1) + (m-1) (n-1) 
(b-1) 
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Then we can figure out formulas for all sum of squares and estimates for each parameter.  
 
Appendix II Method and Rules for EMS Calculation (Taking Model 1 as an 
Example) 
1. Setting down a table. Marking row headings (Sources) as variable terms in 
model and writing down column headings as subscriptions with numbers of 
observations. Here, you need to make sure to add F for fixed levels of factor 
and R for random levels. 
 
2. Filling the table. For each column, if fixed subscription appears in 
corresponding row heading, then writing down 0; otherwise, filling by number 
of observations for that fixed subscription. If random subscription shows up in 
corresponding row heading, then writing down 1; otherwise, filling by number 
of observations for that random subscription. Note that all cells are filled by 1 
in error row, anyway. 
 
 
3.  Calculating degree of freedom for each random variable. Degree of freedom 
is, as usual, computed as number of observation for corresponding 
subscription subtracting 1, or product of them. Total degree of freedom is N-1, 
where N is the production of all numbers of observations.   
 
After first three steps, we can get Appendix IIA for Model 1. Notice that degree 
of freedom for random error term is not computable in this case. 
4. Calculation EMS.  We prefer to take two variable terms, αi, (θβ)jk, in Table A 
as examples for explain the abstract calculation procedure. Since αi is a fixed 
variable and (θβ)jk is random, we can see the slightly difference between fixed 
and random cases.  
 
For αi, we need to list out all variances related to it, firstly. These variance 
contains variance of general random error and all variances with subscriptions containing 
at least the notation of the variance we concern, so these variances are σε2, σαθ2, and σα2. 
No β term is involved since factor B effect (β’s) haven’t added in yet, in this experiment. 
Now, we add coefficients for each term. Coefficients for σε2 are always 1 for any term. To 
find coefficient for σαθ2, we can cover up i and j columns in FRF sector in Table A, we 
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get b, which is the coefficient for σαθ2. Similar procedure can be applied to find the 
coefficient for σα2 by covering up i column, and nb is the coefficient for σα2. Adding them 
together, we get σε2 + bσαθ2 + nbσα2. (A tip here is that it would benefit later by writing 
σε2 as the first term and the term using symbol representing corresponding effect as the 
last one.)  
 
Appendix IIA Degree of freedom for terms in Model 1 
Sources d.f. 
m n b 
F R F 
i j k 
αi m-1 0 n b 
θj n-1 m 1 b 
(αθ)ij (m-1)(n-1) 0 1 b 
βk b-1 0 n 0 
(αβ)ik (m-1)(b-1) 0 n 0 
(θβ)jk (n-1)(b-1) 0 1 0 
(αθβ)ijk (m-1)(n-1)(b-1) 0 1 0 
εijk  1 1 1 
Total mnb-1    
 
Rules start to apply to adjust terms.  
1. First and last terms are always remaining.  
2. For middle variance component of EMS, covering up the symbol representing 
corresponding effect in subscription, α here. If remaining subscription(s) is fixed, 
then dropping out this variance term; otherwise, keeping it. Here, remaining 
subscription is θ, which is random effect, so we keep this term. 
Then we get EMS (αi) = σε2 + bσαθ2 + nbσα2.  
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For (θβ)jk, related variances are σε2, σαθβ2, σθβ2, and coefficients are 1, 1, and m, 
respectively. After apply rule 1 and 2, we get EMS ((θβ)jk) = σε2 + mσθβ2. Now rule 3 
need to be introduced. 
3. If the effect is random, then EMS keeps the same as what we have gotten. If it is 
fixed, we have to replace the variance component of that fixed effect by Sum of 
its squares dividing its degree of freedom. 
So, EMS (αi) turns to be σε2 + bσαθ2 + nb 
∑ 𝛼𝑖
2
𝑖
𝑚−1
. However, EMS ((θβ)jk) keeps the 
same. Together with all other effect terms, we can get Appendix IIB.  
 
Appendix IIB EMS for all terms in model 1 
Sources EMS  
αi σε2 + bσαθ2 + nb 
∑ 𝛼𝑖
2
𝑖
𝑚−1
 
θj σε2 + mbσθ2 
(αθ)ij σε2 + bσαθ2  
βk σε2 + σαθβ2 + mσθβ2 + mn 
∑ 𝛽𝑘
2
𝑘
𝑏−1
       
(αβ)ik σε2 + σαθβ2 + n 
∑ ∑ (𝛼𝛽)𝑖𝑗
2
𝑗𝑖
(𝑚−1)(𝑏−1)
 
(θβ)jk σε2 + mσθβ2                                          
(αθβ)ijk 
εijk 
σε2 + σαθβ2  
σε2 
 
 
Appendix III Matrix Forms for Models 
 
Matrix Form for General Linear Models. Suppose n data 𝑦1, … , 𝑦𝑛 are observed and 
explained by p explanatory variables with n values for each, 𝑥11, … , 𝑥1𝑝, … , 𝑥𝑛1, … , 𝑥𝑛𝑝. 
The model for it is 
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𝑦𝑖 = 𝑥𝑖1𝛽1 +⋯+ 𝑥𝑖𝑝𝛽𝑝 + 𝑒𝑖 
Here β’s are unknown fixed effects parameters and 𝑒𝑖′𝑠 are i.i.d. 
𝑁(0, 𝜎2)distributed random variables/ errors. However, we need to write n equations to 
represent all observations. In order to make the process simpler, we can use a single 
equation by using matrix notations.  
𝐘 = 𝐗𝛃 + 𝐞 
where 
Y represents the vector of all response variables, and 𝐘 = [
𝑦1
⋮
𝑦𝑛
]; 
X is the known matrix of all explanatory variables, and X is defined as [
𝑥11 … 𝑥1𝑝
⋮ ⋱ ⋮
𝑥𝑛1 … 𝑥𝑛𝑝
]; 
β is the unknown fixed effects parameter vector, and 𝛃 = [
𝛽1
⋮
𝛽𝑛
]; and 
e is the random error vector with 𝐞 = [
𝑒1
⋮
𝑒𝑛
] and e follows 𝑁(𝟎,𝑽) where 𝑽 = 𝜎2𝑰. 
 
Matrix Form for General Linear Mixed Models 
 For mixed model, both fixed and random effects are involved, such as repeated-
measures designs. The random effects would allow elements of 𝐘 to be correlated. There 
are two approaches to modify general linear model. 
First, we can change the assumptions made for random error matrix e 
follows 𝑁(𝟎,𝑹). In this case, matrix e is called as covariance matrix. Notice that 
elements in e are not i.i.d. any longer.  
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Second, we can add random effects and coefficients in model. Based on general 
linear model, we can add Zu terms, where Z matrix is a conditional model and u 
follows 𝑁(𝟎,𝑮). At the same time, e follows 𝑁(𝟎, 𝑹). Models without a Z matrix that 
capture complex covariance structure directly through the variance matrix of the errors e 
are called marginal models (Littell 2007). In summary, the second approach concludes as 
following 
𝐘 = 𝐗𝛃 + 𝐙𝐮 + 𝐞 
u follows 𝑁(𝟎, 𝑮) 
e follows 𝑁(𝟎, 𝑹)  
cov[𝐮, 𝐞] = 𝟎 
It’s important to understand that assumption cov[𝐮, 𝐞] = 𝟎 is the key feature to 
avoid parameter confounding. To be specific, 𝐘, 𝐗, 𝛃 denote the vector of response 
variables, the known matrix of all explanatory variables, and the unknown fixed effects 
parameter vector, respectively. New term Z is a matrix filled with 1’s and 0’s depending 
on specific model you use. Vector u contains all random effects, so it is not parameter 
since they are not fixed. 
The conditional distribution of 𝐘|𝐮 and the marginal distribution of 𝐘 are 
𝐘|𝐮 follows 𝑁(𝑿𝜷 + 𝒁𝒖,𝑹) 
𝐘 follows 𝑁(𝑿𝜷, 𝑽) 
𝐕 = 𝒗𝒂𝒓(𝒀) = 𝒁𝑮𝒁′ + 𝑹 
 
Appendix IV Related SAS Codes 
proc import out=signals datafile='C:\Users\yxz195\Desktop\signals.xlsx' 
DBMS=XLSX REPLACE; 
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SHEET="Sheet2"; 
GETNAMES=YES; 
RUN; 
proc transpose data=signals 
out=signals_trans; 
by ID;   /*NOTICE:in order to make SAS recognize ID is sorted with ascending order, 
ID's should be labeled as GENE00001--GENE16436*/ 
VAR _1-_72; 
run; 
data Reduced_names(drop=_NAME_ _LABEL_ ); 
set signals_trans; 
run; 
data Signal (rename=(COL1=Signals)); 
set Reduced_names; 
run; 
/* proc print data=Signal (OBS=100); run; */ 
 
proc import out=Design_matrix datafile='C:\Users\yxz195\Desktop\design.txt' 
DBMS=dlm REPLACE; 
delimiter='09'x;   /*read space-delimited text file into sas*/  
GETNAMES=no; 
RUN;  
data Design (rename=(VAR1=SPE VAR2=TR VAR3=REP VAR4=T)); 
set Design_matrix; 
RUN; 
/* PROC PRINT DATA=Design (OBS=200); RUN; */ 
 
data Thesis; 
set Design ; 
set Signal; 
run; 
/* Proc print data= Thesis (OBS=500); run; */ 
 
data NormData; /*normalized data to make them ready to be analyzed*/ 
set Thesis; 
Y=log2(Signals+1); /*not log2(Signals) since there are some signals are 0 in this 
dataset*/ 
run; 
/* Proc print data=NormData (OBS=720); RUN; */ 
 
/* SPLIT-PLOT DESIGN-GENERAL*/ 
 
Proc glm data=NormData; 
class ID SPE TR T REP; 
model Y = SPE TR SPE*TR T SPE*T T*TR REP(SPE*TR*T)/SS3; 
test h=TR E=SPE*TR; 
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random SPE*TR REP(SPE*TR*T)/test; 
RUN; 
 
Proc mixed data=NormData method=ml; 
class ID SPE TR T REP; 
model Y = SPE TR SPE*TR T SPE*T T*TR; 
random SPE*TR;  
RUN; 
 
These two small programs produce same F-ratios.*/ 
 
/* Gene-Specific Significant Models */ 
 
proc sort data=NormData; 
by ID SPE TR T REP; 
RUN; 
/*Proc print data=NormData (OBS=720); RUN;*/ 
 
/*title 'Scatterplot - Two Variables'; 
proc gplot data= NormData(N=72); 
plot Y*T; 
RUN;*/ 
 
proc import out=genes datafile='C:\Users\yxz195\Desktop\GENES.xlsx' 
DBMS=XLSX REPLACE; 
SHEET="Sheet1"; 
GETNAMES=YES; 
RUN; 
proc print data= gene1; 
run; 
 
ods graphics on; 
title 'Genes Data'; 
proc corr data=gene1 nomiss plots=matrix(histogram); 
var T0 T4 T8 T12 T24 T48; 
run; 
ods graphics off; 
 
/*ods exclude all; 
ods noresults; 
proc mixed data = NormData; 
by ID; 
class ID SPE TR T REP; 
model Y=SPE TR SPE*TR T SPE*T T*TR SPE*TR*T/ outp= NormData1; 
random REP(SPE*TR*T); 
lsmeans SPE TR SPE*TR T SPE*T T*TR SPE*TR*T/diff; 
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ods output covparms=COVparms tests3=Tests3 lsmeans=lsms diffs=Diffs; 
run; 
ods exclude none; 
ods results; 
